Obesity Rules Large-Cap Stocks In First Half Of 2024

 
• By Jessica Merrill and Edwin Elmhirst

Lilly and Novo Nordisk were top performers among large-cap pharma stocks, while the stock prices of Bristol Myers and Gilead declined the most.

Scrip looked at large-cap pharma stock market winners and losers • Source: Shutterstock

More from Strategy

More from Business